Clinical Advisory Board
Dr Sabrina Braham
Dr Sabrina Braham is a Stanford pediatrician and health innovator focused on improving child health through high value care and technology-enabled care models. She is a 2022-23 Stanford Biodesign Faculty Fellow and a current Design, Innovation and Clinical Entrepreneurship Fellow in Stanford’s Clinical Exellence Research Center.
Dr. Michael Cross
Dr. Cross is a Surgical Oncologist specializing in the diagnosis and treatment of medical and surgical diseases of the breast. He is Board-certified by the American Board of Surgery and is now head of the Surgical Oncology Breast Division at Highlands Oncology Group In Northwest Arkansas.
Dr. Fred Dirbas
Dr. Fred Dirbas is an internationally acclaimed surgeon and pioneer in the field of breast cancer who has been practicing medicine for over thirty years. In his twenty five years at Stanford, Dr. Dirbas has established a robust clinical practice and has affected the lives of countless patients.
Dr. Thomas Fogarty
Dr. Thomas J. Fogarty is an American surgeon and inventor of the embolectomy catheter. Before his invention the success rate for removing an embolus, or blood clot, was forty to fifty percent. In 1965, Dr. Thomas Fogarty published an article describing “a new method for extraction of arterial emboli and thrombi.”
Dr. Bob Geng
Dr. Bob Geng is an Associate Clinical Professor of Medicine and Pediatrics at the University of California, San Diego School of Medicine. He is also affiliated with Rady Children’s Hospital.
Dr. Dana Gordon
Dana Gordon, Pharm. D. is a longtime resident of the Monterey Peninsula of California where he has owned and operated Central Avenue Pharmacy (CAPRx, Inc) since 1991 as President and CEO.
Dr. Arthur Hill
Dr. Arthur Hill is a Cardiothoracic Surgeon and Surgical Director of the Cardiac ICU at UCSF. His interests in patient care include general thoracic, adult cardiac surgery, and thoracic trauma surgery.
Dr. Arman Kalamkarian
Dr. Arman Kalamkarian chose internal medicine as his specialty because of his passion for preventative medicine. His mission as a provider in the community is to help keep patients healthy and prevent complications from preventable disease.
Dr. Cary Kaufman
Cary Kaufman is a Clinical Professor of Surgery at the University of Washington and the Medical Director of the Bellingham Regional Breast Center. He trained at UCLA School of Medicine and the University of Washington Departments of Surgery.
Dr. David I. Kaufman
Dr. David I. Kaufman is a leading Breast Cancer Surgeon in the New York area. He is Board Certified by the American Board of Surgery, a Fellow of the American College of Surgeons, a member of the American Society of Breast Surgeons, the Medical Society of the State of New York and the Nassau County Medical Society.
Diana Laurent, PharmD
Diana Laurent, PharmD is a UCSF trained clinical pharmacist with over 30 years of experience in
pharmacy ownership, compounding, preventative medicine and patient care. Her passion is helping
educate patients on how not to need medicine.
Dr. Keith Matheny
Dr. Keith Matheny is a Vanderbilt-trained Otolaryngologist in North Dallas, emphasizing Rhinology & Sleep in adults and children. He has a passion for the business aspects of Otolaryngology, as well as new technology, pharmacotherapy & procedures in ENT.
Dr. Jeffrey Rosenbloom
Jeffrey S. Rosenbloom, MD is a native Texan, born and raised in Dallas and began his San Antonio medical practice in 1999. Dr. Rosenbloom graduated from the University of Texas at Austin and obtained his medical degree from University of Texas Southwestern School of Medicine.
Dr. Jaclyn Tolentino
Dr. Jaclyn Tolentino, is a board-certified Family Physician and Integrative & Functional Medicine practitioner at Parsley Health who lives in Los Angeles, California. She graduated from the Edward via Virginia College of Osteopathic Medicine and completed family medicine residency in Miami, FL.
Corporate Advisory Board
Marc Chaput serves as Partner of Gravitas Healthcare, LLC, a strategic advisory firm that specializes in advising emerging growth medical device companies. He holds a B.A. from Bates College and an M.B.A. from the J.L. Kellogg Graduate School of Management at Northwestern University.
Andy has over 37 years banking and wealth management experience which allowed him to develop a deep understanding of global financial and capital markets, risk management and governance. Previous executive roles have included: Chief Executive of New Zealand Asset Management, General Manager- Europe and Americas at Westpac Bank, Head of Americas at Westpac Bank; Treasurer at Lloyds Bank, Australia and Head of Wealth, Westpac New Zealand.
Mike Musgnug currently serves as the EVP of Strategy for Sapphiros and as CEO of GrapheneDx. Prior to joining Sapphiros, Mr. Musgnug served as CRO at Discovery Life Sciences, where he was responsible for driving top-line growth via organic and inorganic means. Previously, Musgnug served as Vice President and General Manager at Beckman Coulter Life Sciences, a Danaher company. In this role, he was responsible for four product lines totaling more than $1 billion.
David Uffer is a 30+ year seasoned executive having a career dedicated to the Medtech industry. He currently serves as the VP of Medtech at General Inception where he leads investments and company development in early stage Medtech technologies. Prior to General Inception David was the Senior Partner and VP of Medtech at Alira Health, a global advisory firm. He advised companies in all aspects of commercialization while leading transactions as well.